What is post-market surveillance (PMS) and why is it important?

• A. A one-time clinical trial conducted before market release.
• B. A marketing surveillance program to track sales.
• C. Ongoing monitoring of device safety and performance after market release to identify new risks.
• D. A process to phase out outdated devices.

Answer: (C)

Post-market surveillance is the ongoing monitoring of a medical device after it is released to the market to track safety and performance and to identify new risks that weren’t evident in premarket testing. This process collects real-world data from clinicians, patients, registries, and adverse event reports, then analyzes how the device behaves over time in diverse use conditions.

Why this matters? Some issues only show up when a device is used widely, by different patient populations, or over longer periods. PMS helps spot rare or long-term adverse effects, performance problems, or interactions with other therapies. It supports patient safety by triggering updates to labeling or instructions, additional training, design changes, safety communications, or even recalls if necessary. It also keeps the product development cycle informed, so improvements can be made and risks managed throughout the device’s life.

It’s not about a one-time premarket trial, nor is it simply tracking sales, nor a plan to phase out devices by itself. It’s an ongoing, systematic way to ensure continued safety and effectiveness after broad clinical use.